122 related articles for article (PubMed ID: 26872058)
21. Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.
Robinson LR; Whelan SP
J Virol; 2016 Jan; 90(7):3640-9. PubMed ID: 26792739
[TBL] [Abstract][Full Text] [Related]
22. The human endogenous retrovirus K(HML-2) has a broad envelope-mediated cellular tropism and is prone to inhibition at a post-entry, pre-integration step.
Kramer P; Lausch V; Volkwein A; Hanke K; Hohn O; Bannert N
Virology; 2016 Jan; 487():121-8. PubMed ID: 26517399
[TBL] [Abstract][Full Text] [Related]
23. GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study.
Curtin F; Lang AB; Perron H; Laumonier M; Vidal V; Porchet HC; Hartung HP
Clin Ther; 2012 Dec; 34(12):2268-78. PubMed ID: 23200102
[TBL] [Abstract][Full Text] [Related]
24. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines.
Büscher K; Trefzer U; Hofmann M; Sterry W; Kurth R; Denner J
Cancer Res; 2005 May; 65(10):4172-80. PubMed ID: 15899808
[TBL] [Abstract][Full Text] [Related]
25. Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma.
Rakoff-Nahoum S; Kuebler PJ; Heymann JJ; E Sheehy M; Ortiz GM; S Ogg G; Barbour JD; Lenz J; Steinfeld AD; Nixon DF
AIDS Res Hum Retroviruses; 2006 Jan; 22(1):52-6. PubMed ID: 16438646
[TBL] [Abstract][Full Text] [Related]
26. Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein.
Reis BS; Jungbluth AA; Frosina D; Holz M; Ritter E; Nakayama E; Ishida T; Obata Y; Carver B; Scher H; Scardino PT; Slovin S; Subudhi SK; Reuter VE; Savage C; Allison JP; Melamed J; Jäger E; Ritter G; Old LJ; Gnjatic S
Clin Cancer Res; 2013 Nov; 19(22):6112-25. PubMed ID: 24081977
[TBL] [Abstract][Full Text] [Related]
27. Insertional polymorphisms of endogenous HERV-K113 and HERV-K115 retroviruses in breast cancer patients and age-matched controls.
Burmeister T; Ebert AD; Pritze W; Loddenkemper C; Schwartz S; Thiel E
AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1223-9. PubMed ID: 15588344
[TBL] [Abstract][Full Text] [Related]
28. Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer.
Contreras-Galindo R; Kaplan MH; Leissner P; Verjat T; Ferlenghi I; Bagnoli F; Giusti F; Dosik MH; Hayes DF; Gitlin SD; Markovitz DM
J Virol; 2008 Oct; 82(19):9329-36. PubMed ID: 18632860
[TBL] [Abstract][Full Text] [Related]
29. A novel multiplex RT-PCR system detects human endogenous retrovirus-K in breast cancer.
Ejthadi HD; Martin JH; Junying J; Roden DA; Lahiri M; Warren P; Murray PG; Nelson PN
Arch Virol; 2005 Jan; 150(1):177-84. PubMed ID: 15449135
[TBL] [Abstract][Full Text] [Related]
30. Antibodies in human sera recognizing a recombinant outer membrane protein encoded by the envelope gene of the human endogenous retrovirus K.
Vogetseder W; Dumfahrt A; Mayersbach P; Schönitzer D; Dierich MP
AIDS Res Hum Retroviruses; 1993 Jul; 9(7):687-94. PubMed ID: 8396402
[TBL] [Abstract][Full Text] [Related]
31. Regulation of human endogenous retrovirus-K expression in melanomas by CpG methylation.
Stengel S; Fiebig U; Kurth R; Denner J
Genes Chromosomes Cancer; 2010 May; 49(5):401-11. PubMed ID: 20095041
[TBL] [Abstract][Full Text] [Related]
32. Expression of the human endogenous retrovirus-K transmembrane envelope, Rec and Np9 proteins in melanomas and melanoma cell lines.
Büscher K; Hahn S; Hofmann M; Trefzer U; Ozel M; Sterry W; Löwer J; Löwer R; Kurth R; Denner J
Melanoma Res; 2006 Jun; 16(3):223-34. PubMed ID: 16718269
[TBL] [Abstract][Full Text] [Related]
33. The envelope glycoprotein of human endogenous retrovirus HERV-W induces cellular resistance to spleen necrosis virus.
Ponferrada VG; Mauck BS; Wooley DP
Arch Virol; 2003 Apr; 148(4):659-75. PubMed ID: 12664292
[TBL] [Abstract][Full Text] [Related]
34. Env gene expression of human endogenous retrovirus-k and human endogenous retrovirus-w in childhood acute leukemia cells.
Januszkiewicz-Lewandowska D; Nowicka K; Rembowska J; Fichna M; Żurawek M; Derwich K; Nowak J
Acta Haematol; 2013; 129(4):232-7. PubMed ID: 23328642
[TBL] [Abstract][Full Text] [Related]
35. Increase in human endogenous retrovirus HERV-K (HML-2) viral load in active rheumatoid arthritis.
Reynier F; Verjat T; Turrel F; Imbert PE; Marotte H; Mougin B; Miossec P
Scand J Immunol; 2009 Sep; 70(3):295-9. PubMed ID: 19703019
[TBL] [Abstract][Full Text] [Related]
36. Human endogenous retrovirus-R Env glycoprotein as possible autoantigen in autoimmune disease.
Sasaki N; Ogawa Y; Iinuma C; Tomaru U; Katsumata K; Otsuka N; Kasahara M; Yoshiki T; Ishizu A
AIDS Res Hum Retroviruses; 2009 Sep; 25(9):889-96. PubMed ID: 19689191
[TBL] [Abstract][Full Text] [Related]
37. Human endogenous retrovirus envelope proteins target dendritic cells to suppress T-cell activation.
Hummel J; Kämmerer U; Müller N; Avota E; Schneider-Schaulies S
Eur J Immunol; 2015 Jun; 45(6):1748-59. PubMed ID: 25752285
[TBL] [Abstract][Full Text] [Related]
38. Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity.
Mayer J; Ehlhardt S; Seifert M; Sauter M; Müller-Lantzsch N; Mehraein Y; Zang KD; Meese E
Virology; 2004 Apr; 322(1):190-8. PubMed ID: 15063128
[TBL] [Abstract][Full Text] [Related]
39. Induction of immunoregulatory CD271+ cells by metastatic tumor cells that express human endogenous retrovirus H.
Kudo-Saito C; Yura M; Yamamoto R; Kawakami Y
Cancer Res; 2014 Mar; 74(5):1361-70. PubMed ID: 24590808
[TBL] [Abstract][Full Text] [Related]
40. Molecular biology of type A endogenous retrovirus.
Ono M
Kitasato Arch Exp Med; 1990 Sep; 63(2-3):77-90. PubMed ID: 1710682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
